vialroom

#retatrutide 2026-05-06

Wednesday48 messages8 participantstimes are UTC
Highlights from this day
  • karl_fischer — there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists, thats one data point 06:38
  • swab_dry_first — TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule 10:35
  • deamidation — anyone logging resting heart rate on this 12:00
  • deamidation — whats a sensible starting point, im seeing everything from 0.5 to 2 12:12
BS

Janoshik came back 99.4 on one lot and 99 on the next from the same SWB, both fine

GI was about the same as tirzepatide for me, the difference was how fast it arrived

LU

my resting heart rate is up about 7 bpm, did that settle for anyone

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists, thats one data point

👍1🎉12
BS

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely, ask me again in a month

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan

BS

the half life supports weekly dosing and thats what ive done from the start

BS

im at 2.5 and the appetite effect is stronger than i expected, normal

does the glucagon arm explain the heart rate or is that unrelated

BS

held at 2 for 16 months and it never plateaued for me, which i cant explain, anyway

reconstituted the 2 vial to 10mg/ml specifically so i could take 0.5 without measuring crumbs

whats the half life like, is it weekly the same way

VL

why does everyone insist on smaller steps here than on the other two

BS

my resting rate went up 5 bpm in the first month and came back most of the way by month 13, your mileage will differ

VL

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

research use only

did the phase 2 plateau or was it still moving at the end

BS

triple agonist meaning GLP-1, GIP and glucagon, have i got that right

watching my heart rate

OS

does the energy expenditure claim show up as anything you can feel

NP

appetite suppression at 12 was stronger than my tirzepatide experience at a comparable point

the purity spread across lots worries me more than the molecule does

TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule

fridge-thermometer.png
800 × 800 · 430 KB · not retained in the public archive
😂2🤝16

logging rhr daily

SD

blood pressure stayed flat for me while heart rate moved, which i didnt expect

LU

low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom

i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps

DE

while im here stepping in 7.5 increments instead of doubling is the only thing i would change if i started again

quick one triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, still working it out

i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind

LU

genuine question i log resting heart rate every morning because of this and its the one number i actually watch, ymmv

DE

whats a sensible starting point, im seeing everything from 0.5 to 2

🔥4👀9🙏15